- Home
- QNCX vs SRBK Comparison
QNCX vs SRBK Comparison
Compare QNCX & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- SRBK
- Stock Information
- Founded
- QNCX 2012
- SRBK 1887
- Country
- QNCX United States
- SRBK United States
- Employees
- QNCX N/A
- SRBK N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- SRBK
- Sector
- QNCX Health Care
- SRBK
- Exchange
- QNCX Nasdaq
- SRBK Nasdaq
- Market Cap
- QNCX 100.4M
- SRBK 117.4M
- IPO Year
- QNCX 2019
- SRBK N/A
- Fundamental
- Price
- QNCX $1.98
- SRBK $14.73
- Analyst Decision
- QNCX Strong Buy
- SRBK
- Analyst Count
- QNCX 6
- SRBK 0
- Target Price
- QNCX $8.00
- SRBK N/A
- AVG Volume (30 Days)
- QNCX 431.7K
- SRBK 34.8K
- Earning Date
- QNCX 11-12-2025
- SRBK 10-31-2025
- Dividend Yield
- QNCX N/A
- SRBK 1.35%
- EPS Growth
- QNCX N/A
- SRBK N/A
- EPS
- QNCX N/A
- SRBK 0.61
- Revenue
- QNCX N/A
- SRBK $31,690,000.00
- Revenue This Year
- QNCX N/A
- SRBK N/A
- Revenue Next Year
- QNCX N/A
- SRBK N/A
- P/E Ratio
- QNCX N/A
- SRBK $24.26
- Revenue Growth
- QNCX N/A
- SRBK 38.91
- 52 Week Low
- QNCX $0.71
- SRBK $10.54
- 52 Week High
- QNCX $2.45
- SRBK $15.46
- Technical
- Relative Strength Index (RSI)
- QNCX 62.46
- SRBK 47.43
- Support Level
- QNCX $1.82
- SRBK $14.39
- Resistance Level
- QNCX $2.01
- SRBK $15.03
- Average True Range (ATR)
- QNCX 0.16
- SRBK 0.24
- MACD
- QNCX 0.03
- SRBK -0.06
- Stochastic Oscillator
- QNCX 64.48
- SRBK 36.47
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About SRBK SR Bancorp Inc. Common stock
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.